Circulating matrix modulators (MMP-9 and TIMP-1) and their association with severity of diabetic retinopathy.
AIMS: Diabetic Retinopathy (DR) is the leading cause of vision loss in the working age population. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1), are molecules involved in extracellular tissue matrix remodelling. ..... Read More